|
TTLL4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.44780000000245E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06969999999584E-05 |
| Normal-vs-Stage2 |
3.20440000090016E-08 |
| Normal-vs-Stage3 |
3.07259999665632E-08 |
| Normal-vs-Stage4 |
5.58729999999841E-05 |
| Stage1-vs-Stage2 |
1.057840E-02 |
| Stage1-vs-Stage3 |
5.986100E-02 |
| Stage1-vs-Stage4 |
5.458000E-01 |
| Stage2-vs-Stage3 |
4.186600E-01 |
| Stage2-vs-Stage4 |
1.460600E-01 |
| Stage3-vs-Stage4 |
4.207400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.11850000004277E-07 |
| Normal-vs-AfricanAmerican |
2.241200E-03 |
| Normal-vs-Asian |
8.366800E-04 |
| Caucasian-vs-AfricanAmerican |
8.755600E-01 |
| Caucasian-vs-Asian |
4.846400E-01 |
| AfricanAmerican-vs-Asian |
7.204800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.30509999976647E-08 |
| Normal-vs-Female |
5.47960000041314E-07 |
| Male-vs-Female |
3.023600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.13079999999266E-05 |
| Normal-vs-Age(41-60Yrs) |
7.25000000034726E-08 |
| Normal-vs-Age(61-80Yrs) |
7.66999999957108E-07 |
| Normal-vs-Age(81-100Yrs) |
5.002300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.454760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.589200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.265000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.267400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.159200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.841000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.929190E-01 |
| Classical-VS-Follicular |
1.218980E-03 |
| Classical-VS-Other |
2.488800E-01 |
| Classical-VS-Normal |
2.09099999999296E-05 |
| Tall-VS-Follicular |
4.518600E-01 |
| Tall-VS-Other |
6.069000E-01 |
| Tall-VS-Normal |
6.0893999999978E-05 |
| Follicular-VS-Other |
9.378800E-01 |
| Follicular-VS-Normal |
3.83150000615728E-09 |
| Other-VS-Normal |
4.883800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.60430000015499E-07 |
| Normal-vs-N1 |
2.10749999995929E-06 |
| N0-vs-N1 |
6.490400E-01 |
|
|
